What is a stated advantage of multitarget stool DNA testing?

What is a stated advantage of multitarget stool DNA testing?

• A. No diet/med changes
• B. Requires bowel prep
• C. Low sensitivity
• D. Only detects polyps

Answer: (A)

The main concept here is that multitarget stool DNA testing offers a convenient, noninvasive approach to colorectal cancer screening that doesn’t require any changes to your diet or medications or any bowel preparation. You collect a stool sample at home, and the test looks for DNA markers associated with cancer and advanced polyps, potentially increasing detection compared with simpler tests. This is why the stated advantage is the best answer: no diet or medication changes are needed, making it easier for people to complete screening. In contrast, saying that it requires bowel prep is incorrect, because there is no bowel cleansing step involved. It’s also not a test characterized by low sensitivity—multitarget stool DNA testing is designed to have higher sensitivity than some alternatives like FIT. And it doesn’t only detect polyps; it detects cancer-associated DNA changes in addition to hemoglobin, so the option implying it detects only polyps isn’t accurate.

The main concept here is that multitarget stool DNA testing offers a convenient, noninvasive approach to colorectal cancer screening that doesn’t require any changes to your diet or medications or any bowel preparation. You collect a stool sample at home, and the test looks for DNA markers associated with cancer and advanced polyps, potentially increasing detection compared with simpler tests.

This is why the stated advantage is the best answer: no diet or medication changes are needed, making it easier for people to complete screening. In contrast, saying that it requires bowel prep is incorrect, because there is no bowel cleansing step involved. It’s also not a test characterized by low sensitivity—multitarget stool DNA testing is designed to have higher sensitivity than some alternatives like FIT. And it doesn’t only detect polyps; it detects cancer-associated DNA changes in addition to hemoglobin, so the option implying it detects only polyps isn’t accurate.